Benchmark indices Sensex and Nifty 50 closed higher on Tuesday, May 19, with Sensex gaining 369.66 points (0.49%) to open at 75,684.70 and Nifty 50 rising 56.80 points (0.24%) to open at 23,706.75. According to ET Now, the Sensex traded between a high of 75,741.84 and a low of 75,371.07, while the Nifty moved between 23,768.95 and 23,647.40. The positive momentum reflects continued investor interest amid the ongoing earnings season, with market participants closely watching the Q4 results from over 120 companies scheduled to announce their quarterly performance today.
Infosys Ltd emerged as the top gainer, rising 4.47% to ₹1,193.60, followed by Tech Mahindra Ltd which gained 3.88% to ₹1,485.50. HCL Technologies Ltd and Tata Consultancy Services Ltd also posted strong gains of 3.51% and 3.09% respectively, while Adani Enterprises Ltd advanced 2.59% to ₹2,759.50. On the losing side, Hindalco Industries Ltd declined 1.20% to ₹1,040.50, with Oil & Natural Gas Corpn Ltd falling 0.98% to ₹294.30 and Coal India Ltd dropping 0.85% to ₹458.15. Cipla Ltd also underperformed with a 0.63% decline to ₹1,417.20.
More than 120 companies are scheduled to release their financial results for the quarter ended December 31, 2026, on Tuesday, May 19. According to reports from The Hindu BusinessLine, the earnings announcements include major companies such as Bharat Electronics, Bharat Petroleum Corporation, Mankind Pharma, Zydus Lifesciences, and Zee Entertainment Enterprises. Stock-specific action is expected to remain elevated due to these key Q4 earnings announcements, with major companies to watch including BPCL, Bharat Electronics (BEL), and Zydus Lifesciences, where earnings commentary and forward guidance may influence sectoral momentum.
According to brokerage firm Motilal Oswal, BEL is expected to deliver revenue growth of 14% YoY, led by healthy execution of the opening order book of ₹730 billion. The company released provisional figures reporting orders worth ₹300 billion, including export orders valued at $346 million. Revenue, excluding other operating income, stood at ₹268 billion, marking a 16% year-on-year increase, while export revenue rose 34% YoY to $142 million. Key monitorables include updates on orders for QRSAM, Uttam radars, next-gen corvettes, Shatrughat EW, and Akash-NG missile systems, as well as the status of EoI for AMCA.
As reported by Kotak Institutional Equities, Mankind Pharma is expected to achieve 10% YoY sales growth rate for its organic domestic business in Q4FY26, compared to the 9% YoY growth rate in Q3FY26. The brokerage firm anticipates 5% YoY growth in the organic international business, with overall organic business expected to grow 9% YoY in Q4FY26. For BSV, quarterly sales are projected to grow 10% YoY (-1% QoQ) due to the impact of the West Asia conflict on its international business. The firm forecasts 110 bps YoY decline in gross margin to 70.5% in Q4FY26, with consolidated reported EBITDA expected to grow 11% YoY (-18% QoQ) to ₹7.6 billion.
According to The Hindu BusinessLine, the comprehensive list of companies reporting Q4 results today includes PI Industries, Anthem Biosciences, Hatsun Agro Product, Godawari Power and Ispat, BASF India, Fine Organic Industries, PG Electroplast, Trident, Shaily Engineering Plastics, BLS International Services, RITES, Viyash Life Sciences, BlackBuck, Eureka Forbes, Healthcare Global Enterprises, Karnataka Bank, ASK Automotive, Orkla India, TSF Investments, Zee Entertainment Enterprises, and Dynamatic Technologies. The extensive list spans multiple sectors including pharmaceuticals, FMCG, banking, and industrial companies.
